GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Melodiol Global Health Ltd (ASX:ME1DA) » Definitions » Net Margin %

Melodiol Global Health (ASX:ME1DA) Net Margin % : -202.88% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Melodiol Global Health Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Melodiol Global Health's Net Income for the six months ended in Dec. 2023 was A$-24.20 Mil. Melodiol Global Health's Revenue for the six months ended in Dec. 2023 was A$11.93 Mil. Therefore, Melodiol Global Health's net margin for the quarter that ended in Dec. 2023 was -202.88%.

The historical rank and industry rank for Melodiol Global Health's Net Margin % or its related term are showing as below:

ASX:ME1DA' s Net Margin % Range Over the Past 10 Years
Min: -57300   Med: -870.16   Max: -277.18
Current: -277.18


ASX:ME1DA's Net Margin % is ranked worse than
90.59% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 3.5 vs ASX:ME1DA: -277.18

Melodiol Global Health Net Margin % Historical Data

The historical data trend for Melodiol Global Health's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Melodiol Global Health Net Margin % Chart

Melodiol Global Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial -415.17 -1,257.35 -482.97 -377.28 -277.18

Melodiol Global Health Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -347.16 -164.23 -587.65 -403.87 -202.88

Competitive Comparison of Melodiol Global Health's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Melodiol Global Health's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's Net Margin % distribution charts can be found below:

* The bar in red indicates where Melodiol Global Health's Net Margin % falls into.



Melodiol Global Health Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Melodiol Global Health's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-52.446/18.921
=-277.18 %

Melodiol Global Health's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-24.195/11.926
=-202.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Melodiol Global Health  (ASX:ME1DA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Melodiol Global Health Net Margin % Related Terms

Thank you for viewing the detailed overview of Melodiol Global Health's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Melodiol Global Health (ASX:ME1DA) Business Description

Traded in Other Exchanges
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Melodiol Global Health (ASX:ME1DA) Headlines

No Headlines